Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 31:14:3459-3476.
doi: 10.2147/IDR.S315727. eCollection 2021.

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety

Maria Teresa Mascellino  1 , Federica Di Timoteo  1 , Massimiliano De Angelis  1 , Alessandra Oliva  1
Affiliations
Review

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety

Maria Teresa Mascellino et al. Infect Drug Resist. .

Abstract

This review takes into consideration the principal vaccines developed against the SARS-CoV-2 in this unprecedented period of Covid-19 pandemic. We evaluated the mechanism of action of each vaccine as well as the efficacy, the safety and the storage temperature. In addition, the problem of the dose units, the vaccinal strategy, the activity of alternative compounds such as the monoclonal antibodies and especially the issue of the virus variants were also described in detail. Four vaccines are currently used in Italy: Pfizer-BioNTech mRNA BNT162b2 (Comirnaty) (USA), Moderna mRNA 1273 (USA), Astra-Zeneca ChAdOx1-S (recombinant) viral vector adenovirus belonging to Oxford (UK) and Pomezia (Italy), Janssen (two recombinant viral vector adenoviruses) belonging to Johnson & Johnson (USA). The efficacy of Pfizer and Moderna for preventing disease or severe disease results 95-87.5% and 94.5-100%, respectively. The efficacy of Astra-Zeneca and Janssen is about 70% and 65%, respectively; in the case of Janssen, it depends on the geographical area ranging from 72% to 57%. The problem of the administrated doses (one dose, two doses from the same vaccine or from different vaccines, half dose) is also discussed. The vaccination strategy based on the age group remains the simplest, most transparent and fair criterion. This strategy is also based on accelerating the administration of the vaccines, so that as many subjects as possible can be vaccinated quickly for achieving the "herd immunity". The monoclonal antibodies appeared to be a valid solution for the treatment of Covid-19 disease. Two antibodies (bamlanivimab and etesevimab) have just been approved by the FDA. They could also be used for the infection by virus variants which represent a big problem due to their higher transmissibility and virulence and to their lower response to the vaccines.

Keywords: Covid-19 vaccines; dose units; monoclonal antibodies; vaccinal platforms; vaccinal strategy; virus variants.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Scheme of mechanism of action of vaccines Pfizer-BioNTech and Moderna. Created with BioRender.com.
Figure 2
Figure 2
Scheme of mechanism of action of vaccine Astra-Zeneca. Created with BioRender.com.
See this image and copyright information in PMC

Comment in

References

    1. Kumar S, Nyodu R, Maurya VK, Saxena SK.Morphology, genome organization, replication, and pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). coronavirus disease 2019 (COVID-19). Coronavirus Dis. 2020:23–31. doi:10.1007/978-981-15-4814-7_3 - DOI
    1. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423. doi:10.1002/jmv.25681 - DOI - PMC - PubMed
    1. Ho D, Tsuji M. Infectious diseases: breakthroughs in developing vaccines, immune protective monitoring and measuring toxicity with functional proteomics. Isoplexis e-Book. 2020;3. Available from: https://isoplexis.com/literature/infectious-disease-breakthroughs-in-dev....
    1. Ball P. The lightning-fast quest for COVID vaccines – and what it means for other disease. Nature. 2021;508:16–18. doi:10.1038/d41586-020-03626-1 - DOI - PubMed
    1. Ravichandran S, Coyle E, Klenow L, Tang J, Grubbs G, Liu S. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits. Sci Transl Med. 2020;12(550):eabc3539. doi:10.1126/scitranslmed.abc3539 - DOI - PMC - PubMed